首页> 外国专利> Protein C derivatives and Pharmaceutical compositions made with such Derivatives, recombinant DNA molecules encoding such derivatives; Transforming vectors containing Said derivatives; isolated Nucleic Acids comprising polynucleotides that encode at least 90 d

Protein C derivatives and Pharmaceutical compositions made with such Derivatives, recombinant DNA molecules encoding such derivatives; Transforming vectors containing Said derivatives; isolated Nucleic Acids comprising polynucleotides that encode at least 90 d

机译:蛋白C衍生物和用这种衍生物制成的药物组合物,编码这种衍生物的重组DNA分子;含有所述衍生物的转化载体;分离的核酸,包含编码至少90%d的多核苷酸

摘要

Describe and claim New Derivatives of Protein C. are polypeptides that retain the Biological activity of the wild type Human protein C, with half lives in human blood is substantially larger.These polypeptides will require less frequent Dosing and / or a dosage lower than that of the wild type Human protein C in the treatment of vascular occlusive disorders, Hypercoagulable States and diseases that predispose to thrombosis. Specifically, it is derived from the Human protein C comprising SEQ ID NS1.Also, describe and claim the remaining Objects mentioned in the title.
机译:描述并声称蛋白C的新衍生物是保留了野生型人蛋白C的生物活性的多肽,在人血中的半衰期大大延长,这些多肽需要的给药频率更低,剂量更低。在治疗血管闭塞性疾病,高凝状态和易形成血栓的疾病中使用野生型人C蛋白。具体而言,它衍生自包含SEQ ID NS1的人蛋白质C。此外,请描述并主张标题中提及的其余对象。

著录项

  • 公开/公告号AR029627A1

    专利类型

  • 公开/公告日2003-07-10

    原文格式PDF

  • 申请/专利权人 ELI LILLY AND COMPANY;

    申请/专利号AR2000P101970

  • 发明设计人

    申请日2000-04-26

  • 分类号C12N15/57;C12N9/64;C12N5/10;A61K38/48;

  • 国家 AR

  • 入库时间 2022-08-22 00:04:01

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号